Review Article
Microneedles: As a Novel Carrier for Transdermal Drug Delivery System
- K Sai Krithi
- Krishna Sailaja *
Department of Pharmaceutics, RBVRR Women’s College of Pharmacy, Barkatpura Hyderabad, India.
*Corresponding Author: Krishna Sailaja, Department of Pharmaceutics, RBVRR Women’s College of Pharmacy, Barkatpura Hyderabad, India.
Citation: K Sai Krithi, Sailaja K. (2025). Microneedles: As a Novel Carrier for Transdermal Drug Delivery System, Clinical Case Reports and Studies, BioRes Scientia Publishers. 11(2):1-5. DOI: 10.59657/2837-2565.brs.25.289
Copyright: © 2025 Krishna Sailaja, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: November 03, 2025 | Accepted: November 17, 2025 | Published: November 24, 2025
Abstract
Microneedles offer a novel method for drug delivery by blending the benefits of conventional injections and transdermal patches, while reducing the limitations associated with both. These tiny needles can gently poke through the top layer of the skin without hurting. This helps medicine go straight into the skin where it works best. Because they avoid the stomach and liver, microneedles are great for giving medicines that don’t work well when taken by mouth. Depending on the application, microneedles can be fabricated in various forms—solid, coated, dissolvable, or hydrogel-based, each tailored for specific delivery goals such as rapid release or sustained delivery. Their ease of use, potential for self-administration, and reduced risk of infection make microneedles a promising tool in fields like vaccination, chronic disease treatment, and cosmetic therapy. This abstract explores the design principles, benefits, and emerging applications of microneedle technology, as well as the challenges that must be addressed for its broader clinical adoption.
Keywords: microneedles; drug; mouth
Introduction
Oral drug delivery is easy and convenient, allowing patients to take medications on their own. however, it poses challenges when used for delivering biopharmaceuticals. Injections provide fast-acting drug effects and ensure high bioavailability. However, administering injections typically requires trained personnel, and patient adherence is often limited [1,2]. Thus, the perfect drug delivery system would combine the ease of oral administration with the high bioavailability achieved by injections. Transdermal delivery helps drugs bypass the liver’s first-pass metabolism and allows for extended release over time. However, the outermost layer of the skin, the stratum corneum, serves as a barrier that makes it difficult for drugs to penetrate.
Microneedles
The idea of microneedles was first proposed in 1976 but did not become practical until the development of microelectromechanical systems (MEMS) technology in 1998, which also marked the issuance of the first U.S. patent for microneedles designed for transdermal drug delivery. Microneedles offer a patient-friendly method for drug administration with high bioavailability, enabling painless and minimally invasive penetration through the skin’s outermost layer, the stratum corneum. They are engineered to pierce the epidermis and deliver drugs directly into the subepidermal blood vessels. Typically, microneedles have a sharp, tapered tip with lengths ranging from 150 to 1500 micrometers, widths between 50 and 250 micrometers, and tip thicknesses of 1 to 25 micrometers. Common materials used for their fabrication include metals, silicon, polymers, glass, and ceramics. The medication is generally incorporated onto or inside the microneedle tips, which are arranged in arrays attached to a base substrate. This array is then fixed onto a patch with an adhesive backing to ensure secure skin contact and convenient application.
Advantages
- Drug effects begin quickly after administration.
- Microneedles circumvent the first-pass metabolic process.
- Controlled microneedle formulations ensure accurate dosing.
- Their minimal size and length make microneedles both safe and painless.
Disadvantages
- Temporary inflammation and allergic reactions may occur.
- Advanced manufacturing techniques are required to produce microneedle patches consistently.
- Proper storage containers are necessary to keep microneedle patches hygienic and intact during transport from manufacturers to patients.
- When using solid microneedles, fragments can sometimes break off or remain embedded in the skin.
Types of Microneeedles
The microneedles are typically classified into four types:
Solid microneedles.
Coated microneedles.
Dissolving microneedles.
Hydrogel microneedles.
(i) Types of microneedles
Solid Microneedles
Solid microneedles are usually made from metal or silicon, making them strong and without any medicine inside. They have many small, sharp tips made from one material that can poke the skin to make tiny holes. After that, medicine can be applied on the skin using a regular patch or cream over the area.
Coated Microneedles
Coated microneedles are placed directly on the skin and deliver the drug right away. These microneedles have a solid surface covered with a water-soluble layer that melts quickly and releases the drug when inserted. The coating needs to stay stable on the needle and stick well during storage and use. To do this, the coating must have the right thickness or thickness level. This design helps the drug dissolve fast in the skin, so it works quickly.
Dissolving Microneedles
Dissolving microneedles are made from materials that can dissolve in water or break down in the body, and they carry the medicine while being strong enough to pierce the skin. Once they are inserted, these microneedles quickly dissolve when they touch the moisture in the skin, so there is no sharp waste left behind. They are often made from biodegradable materials like cellulose-based polymers such as carboxymethyl cellulose (CMC) and methyl cellulose. The base part that holds the needles usually does not contain the drug and may be thicker, weaker, or made from materials that don’t dissolve in water.
Hydrogel Microneedles
In hydrogel microneedles, the medicine is spread throughout the needle tips, base, and patch, and it is released slowly while the patch stays on the skin. These patches are mostly made of hydrogel, which soaks up moisture from the skin but doesn’t dissolve. A good amount of the medicine moves into the skin by slowly spreading from the hydrogel. Because the medicine is spread all over the patch, this method works well for giving larger doses, but it takes longer, so the patch needs to stay on the skin for a while.
Microneedles Technology Applications
Microneedles anti-cancer agents
Recently, cancer vaccines, including immune-based and gene therapies, have shown promising anti-cancer results and attracted significant attention within the scientific community. Microneedles are capable of penetrating the skin’s stratum corneum to depths typically greater than 200 µm, releasing their drug payload when they come into contact with interstitial fluid. This characteristic makes microneedles valuable tools for transdermal delivery in cancer treatment. Unlike traditional hypodermic needles, which can cause pain, irritation, and generate hazardous waste, microneedle drug delivery systems greatly reduce these side effects.
Moreover, microneedles can deliver vaccines in a dried solid form, improving their thermal stability and simplifying administration to the target area.
(a) For the combined treatment of superficial tumors, dissolvable microneedles made from hyaluronic acid (HA) were loaded with DOX. These drug-loaded microneedles were integrated with gold nanocages and then exposed to near-infrared light, enabling a synergistic effect of chemotherapy and photothermal therapy.
(b) In melanoma immunotherapy, an anti-PD1 antibody was incorporated into an HA-based microneedle system, combining PD1 blockade with 1-MT to inhibit the enzyme IDO, offering a novel immune-based treatment approach for melanoma.
Diabetes
n studies with diabetic rats, insulin given through microneedles was absorbed by the skin within one hour after the needles dissolved. In one test, insulin-coated metal microneedles were put on the skin to lower blood sugar in diabetic rats. Results showed these microneedles helped insulin get into the skin better and lowered blood sugar by 80%. Dissolving microneedles break apart in about five minutes, quickly releasing insulin into the skin. One study tested these in diabetic rats. About 92% of the insulin stayed effective after being delivered by dissolving microneedles.
Bacterial Disease
Studies have found that a patch that can stop bacterial infections and help tissue heal is very useful for wound care.
Chitosan, a common material used in wound treatment, has natural antibacterial properties. Researchers created a patch made from chitosan microneedles (CSMNA) that uses a smart, temperature-sensitive system to improve wound healing. The tiny needles in the patch help deliver medicine directly to the wound while reducing unwanted sticking between the skin and the patch. The patch also contains a growth factor called VEGF inside a temperature-sensitive gel within the microneedle pores. This gel releases the medicine based on temperature changes caused by inflammation at the wound, allowing the drug to be released only when needed. Tests showed that the CSMNA patch helps new blood vessels grow and supports tissue repair, showing promise for use in real wound treatments.
Occular Microneedle Delivery
Eye conditions are commonly managed with eye drops or ointments, but these methods have drawbacks such as the need for frequent application, low bioavailability, and difficulty penetrating various ocular barriers. Microneedles offer a promising new delivery system aimed at improving treatment outcomes for a variety of eye diseases. Advances in pharmaceutical technology have enabled microneedles to deliver drugs locally in a targeted, effective, and minimally invasive manner to the eye. Studies have shown that the developed microneedle devices possess adequate stiffness for reliable insertion into ex vivo rabbit corneas. Furthermore, these microneedles demonstrated the ability to increase drug loading capacity by up to five times compared to solid microneedles of similar dimensions, as well as enhanced drug release beneath the surface of the rabbit cornea. Dissolving microneedles have been found to improve the delivery of large ocular molecules. Various molecular weights of polyvinylpyrrolidone (PVP) polymer were used to fabricate these microneedles. Conical PVP microneedle arrays, approximately 800 μm tall with a base diameter of 300 μm, containing the drug model, were produced, with an average drug load ranging between 0.96 and 9.91 μg per array. Detachable microneedle technology is especially promising for treating eye disorders like keratitis and glaucoma, offering consistent drug delivery with reduced invasiveness. However, reducing the time needed for microneedle administration into target tissues remains a challenge, despite efforts to address this through various mechanical and chemical separation techniques.
Vaccine Therapy
A vaccine is a biological substance that helps the body build immunity against certain diseases. It usually contains a weakened or dead form of the germ, its toxins, or parts of its surface. Vaccines work by activating the immune system to protect against future infections, and microneedle technology has been effective in helping with this. DNA vaccines given through microneedles have triggered stronger immune reactions than regular injections. Scientists are also working on microneedle patches to deliver flu vaccines. Using hollow microneedles means less vaccine is needed compared to regular muscle injections. Research has also tested giving anthrax and rabies vaccines using hollow microneedles.
Cosmetics
Microneedles are becoming more popular in beauty treatments, especially for improving skin look and treating scars and blemishes. Researchers have worked on using microneedles to deliver active cosmetic ingredients like vitamin C (ascorbic acid), eflornithine, and retinyl retinoate. Melanin was put inside tiny fat-based particles called nanoliposomes to help it mix better with oils. When applied with a microneedle roller, more pigment was found near hair follicles. Microneedles also helped improve the delivery of other skin-care compounds like melanostatin, rigin, and pal-KTTKS.
Lidocaine Delivery
Lidocaine is often used to numb areas of the body. Using microneedles to deliver lidocaine causes less pain than regular injections, making it easier for patients to accept. These microneedles can reliably penetrate the skin in lab tests and deliver the drug quickly, within 2 minutes. This makes microneedles a fast and painless way to provide local anesthesia. In one study, microneedles coated with a PEG-lidocaine mix delivered the drug faster within 3 minutes compared to traditional creams or gels.
Table 1: Approved Microneedle Products
| Product name | Company name | Description of the product | Use |
| Dermaroller® | Derma roller Germany, White Lotus | A cylindrical roller with solid or metal microneedles,0.2–2.5mm in length. | Improve skin texture, treat scars and hyperpigmentation. |
| C-8(Cosmetictype) | The Derma roller Series by Anastassakis K | A needle length of only 0.13mm(130μm) | Used to enhance penetration of topical agents. |
| CIT-8(Collagen Induction Therapy | The Derma roller Series by Anastassakis K. | A needle length of 0.5mm (500μm) | Used in collagen induction and skin remodeling. |
| Soluvia® | Sanofi Pasteur Europe | Hollow micro needle attached to a syringe | Influenza vaccination |
| LiteClear® | Nanomed skin care | Solid silicon microneedles are used aspre-treatment and then drug applied topically. | Treats acne and skin blemishes |
| h-patch | Valeritas | Smal l adhesive machine like patch is used | To deliver drugs in subcutaneous tissue(insulin) |
| MF-8type | The Dermaroller Series by Anastassakis K | A needle length of 1.5mm (1500μm) | Treat scars. |
Conclusion
Microneedles represent a rapidly advancing transdermal drug delivery technology, offering improved patient access by serving as an alternative to traditional administration methods. These microneedles can be categorized into solid, coated, dissolving, and hydrogel types, and are fabricated from materials such as silicon, metals, polymers, glass, and ceramics. A variety of manufacturing methods are employed to create microneedles with specific shapes, sizes, and characteristics. The technology is continuously progressing through clinical research involving different medications. Most research findings have been positive, indicating that microneedles hold promise for delivering therapeutic benefits across a wide range of medical applications.
References
- Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004). Current status and future potential of transdermal drug delivery. Nature Reviews Drug Discovery.
Publisher | Google Scholor - Donnelly, R. F., Singh, T. R. R., & Morrow, D. I. J. (2012). Microneedle-mediated transdermal and intradermal drug delivery. John Wiley & Sons.
Publisher | Google Scholor - Lhernould, M. S. (2013). Optimizing hollow microneedles arrays aimed at transdermal drug delivery. Microsystem Technologies, 19.
Publisher | Google Scholor - Tuan-Mahmood, T.-M., McCrudden, M. T. C., Torrisi, B. M., McAlister, E., Garland, M. J., Singh, T. R. R., & Donnelly, R. F. (2013). Microneedles for intradermal and transdermal drug delivery. European Journal of Pharmaceutical Sciences, 50:623–637.
Publisher | Google Scholor - Singh, T., McMillan, H., Mooney, K., Alkilani, A., & Donnelly, R. (2013). Microneedles for drug delivery and monitoring. In Microfluidic devices for biomedical applications. Elsevier.
Publisher | Google Scholor - Demir, Y. K., Akan, Z., & Kerimoglu, O. (2013). Characterization of polymeric microneedle arrays for transdermal drug delivery. PLoS ONE, 8:e77289.
Publisher | Google Scholor - Cheung, K., & Das, D. B. (2014). Microneedles for drug delivery: Trends and progress. Drug Delivery, 23:2338–2354.
Publisher | Google Scholor - Jacoby, E., Jarrahian, C., Hull, H. F., & Zehrung, D. (2015). Opportunities and challenges in delivering influenza vaccine by microneedle patch. Elsevier.
Publisher | Google Scholor - Zhu, D. D., Wang, Q. L., Liu, X. B., & Guo, X. D. (2016). Rapidly separating microneedles for transdermal drug delivery. Acta Biomaterialia, 41:312–319.
Publisher | Google Scholor - Alkilani, A. Z., McCrudden, M. T., & Donnelly, R. F. (2015). Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics, 7:438–470.
Publisher | Google Scholor - Thakur, R. R. S., Al-Shammari, F., Tekko, I. A., McCarthy, H., & Donnelly, R. F. (2016). Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery. Drug Delivery and Translational Research, 6:800–815.
Publisher | Google Scholor - Li, J., Zeng, M., Shan, H., & Tong, C. (2017). Microneedle patches as drug and vaccine delivery platform. Current Medicinal Chemistry, 24:2413–2422.
Publisher | Google Scholor - Kwon, K. M., Lim, S.-M., Choi, S., Kim, D.-H., Jin, H.-E., Jee, G., Hong, K.-J., & Kim, J. Y. (2017). Microneedles: Quick and easy delivery methods of vaccines. Clinical and Experimental Vaccine Research, 6:156–159.
Publisher | Google Scholor - González-Vázquez, P., Larrañeta, E., McCrudden, M. T., Jarrahian, C., Rein-Weston, A., Quintanar-Solares, M., Zehrung, D., McCarthy, H., Courtenay, A. J., & Donnelly, R. F. (2017). Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. Journal of Controlled Release, 265:30–40.
Publisher | Google Scholor - Jeong, H. R., Lee, H. S., Choi, I. J., & Park, J. H. (2017). Considerations in the use of microneedles: Pain, convenience, anxiety and safety. Journal of Drug Targeting, 25, 29–40.
Publisher | Google Scholor - Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2018). Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomedicine & Pharmacotherapy, 109:1249–1258.
Publisher | Google Scholor - Walsh, L. (2019). Microneedling: A versatile and popular treatment option. Journal of Aesthetic Nursing, 8:280–284.
Publisher | Google Scholor - Rodgers, A. M., Cordeiro, A. S., & Donnelly, R. F. (2019). Technology update: Dissolvable microneedle patches for vaccine delivery. Medical Devices, 12:379–398.
Publisher | Google Scholor - Li, Y., Zhang, H., Yang, R., Laffitte, Y., Schmill, U., Hu, W., Kaddoura, M., Blondeel, E. J. M., & Cui, B. (2019). Fabrication of sharp silicon hollow microneedles by deep-reactive ion etching towards minimally invasive diagnostics. Microsystems & Nanoengineering.
Publisher | Google Scholor - Guillot, A. J., Cordeiro, A. S., Donnelly, R. F., Montesinos, M. C., Garrigues, T. M., & Melero, A. (2020). Microneedle-based delivery: An overview of current applications and trends. Pharmaceutics, 12:569.
Publisher | Google Scholor - Sayed, N., Vaut, L., & Schneider, M. (2020). Customized fast-separable microneedles prepared with the aid of 3D printing for nanoparticle delivery. European Journal of Pharmaceutics and Biopharmaceutics, 154:166–174.
Publisher | Google Scholor - Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2021). Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug Delivery and Translational Research.
Publisher | Google Scholor - Jung, J. H., & Jin, S. G. (2021). Microneedle for transdermal delivery: Current trends and fabrication. Journal of Pharmaceutical Investigation, 51:503–517.
Publisher | Google Scholor - Yang, J., Liu, X., Fu, Y., & Song, Y. (2021). Recent advances of microneedles for biomedical applications.
Publisher | Google Scholor - Liu, T., Chen, M., Fu, J., Sun, Y., Lu, C., Quan, G., et al. (2021). Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs. Acta Pharmaceutica Sinica B, 11:2326–2343.
Publisher | Google Scholor - Zhang, X., Chen, G., Yu, Y., Sun, L., & Zhao, Y. Bioinspired adhesive and antibacterial microneedles for versatile transdermal drug delivery.
Publisher | Google Scholor - Liu, F., Cheng, Z., & Yi, H. (2023). NIR light-activatable dissolving microneedle system for melanoma ablation enabled by a combination of ROS-responsive chemotherapy and phototherapy. Journal of Nanobiotechnology, 21:61.
Publisher | Google Scholor - Luo, X., Yang, L., & Cui, Y. (2023). Microneedles: Materials, fabrication, and biomedical applications. Biomedical Microdevices, 25:20.
Publisher | Google Scholor - Wang, C., He, G., Zhao, H., Lu, Y., Jiang, P., & Li, W. (2024). Enhancing deep-seated melanoma therapy through wearable self-powered microneedle patch. Advanced Materials, 36.
Publisher | Google Scholor - Wang, X., Wang, Z., Xiao, M., Li, Z., & Zhu, Z. (2024). Advances in biomedical systems based on microneedles: Design, fabrication, and application. Biomaterials Science, 12:530–563.
Publisher | Google Scholor
